Hutch News
Results per Page:
IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
Phase 1 trial aims to build on response seen in proof-of-concept trial
New insights into the breast milk virome in women with HIV
From the Human Biology Division
Dr. Larry Corey receives public service award from American Society of Gene & Cell Therapy
Sonia Skarlatos Public Service Award recognizes person who has advanced field of gene and cell therapy
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
Location, location, location: therapeutic T cells traffic to HIV reservoirs
From the Kiem Lab, Clinical Research Division
HIV antibody trial results offer 'proof of concept'
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
How do antibodies evolve to kill HIV-infected cells?
From the Overbaugh and Matsen labs, Human Biology and Public Health Sciences Division
Sequence diversity in cancer-causing viruses
From the Mullins lab, University of Washington and the Vaccine and Infectious Disease Division
Modeling the kinetics of an HIV cure
From the Schiffer group, Vaccine and Infectious Disease Division
Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting
The unintended immune consequences of HIV treatments
From the Hladik Lab, Vaccine and Infectious Disease Division
Timothy Ray Brown, who inspired millions living with HIV, dies of leukemia
For more than a decade after a stem cell transplant, he was the only person known to be cured of HIV/AIDS
Benefits outweigh the social stigma of HIV vaccine trial participation
From the HIV Vaccine Trials Network and the University of Washington
After 20 years, Wakefield retires from HIV Vaccine Trials Network
'He created the DNA of our organization'
A3C tandem domain proteins have increased anti-HIV-1 activity and are resistant to antagonism by HIV-1 Vif
From the Emerman laboratory, Human Biology Division
Injectable HIV drug prevents infections
Early data shows fewer infections than with daily pill; trial halted
TRIMs attack: TRIM34 and TRIM5alpha work together to block HIV-1 infection
From the Emerman laboratory, Human Biology and Basic Sciences Divisions